Tykerb 250
Drug Category |
|
Medicinal form |
Tablets |
Active ingredient |
|
Concentration |
250mg |
Manufacturer |
|
Price |
4297 EGP |
Uses
for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2 growth receptor pathway. Approved as front-line therapy in triple positive breast cancer and as an adjuvant therapy when patients have progressed on Herceptin.
Note: The information provided about this drug does not substitute for consulting a doctor.
Direct Access to Pharmacy Through Innovative Portal
Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips
See list pharmacies